Maturity-onset diabetes of the young type 1 (MODY1)-associated mutations R154X and E276Q in hepatocyte nuclear factor 4α (HNF4α) gene impair recruitment of p300, a key transcriptional coactivator

被引:31
作者
Eeckhoute, J [1 ]
Formstecher, P [1 ]
Laine, B [1 ]
机构
[1] Univ H Warembourg, INSERM, U459, Biol Cellulaire Lab, F-59045 Lille, France
关键词
D O I
10.1210/me.15.7.1200
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Hepatocyte nuclear factor 4 alpha (HNF4 alpha) is a nuclear receptor involved in glucose homeostasis and is required for normal p-cell function. Mutations in the HNF4 alpha gene are associated with maturity-onset diabetes of the young type 1. E276Q and R154X mutations were previously shown to impair intrinsic transcriptional activity (without exogenously supplied coactivators) of HNF4 alpha. Given that transcriptional partners of HNF4 alpha modulate its intrinsic transcriptional activity and play crucial roles in HNF alpha function, we investigated the effects of these mutations on potentiation of HNF4 alpha activity by p300, a key coactivator for HNF4 alpha. We show here that loss of HNF4 alpha function by both mutations is increased through impaired physical interaction and functional cooperation between HNF4 alpha and p300. Impairment of p300-mediated potentiation of HNF4 alpha transcriptional activity is of particular importance for the E276Q mutant since its intrinsic transcriptional activity is moderately affected. Together with previous results obtained with chicken ovalbumin upstream promoter-transcription factor II, our results highlight that impairment of recruitment of transcriptional partners represents an important mechanism leading to abnormal HNF4 alpha function resulting from the MODY1 E276Q mutation. The impaired potentiations of HNF4 alpha activity were observed on the promoter of HNF1 alpha, a transcription factor involved in a transcriptional network and required for beta -cell function. Given its involvement in a regulatory signaling cascade, loss of HNF4 alpha function may cause reduced beta -cell Function secondary to defective HNF1 alpha expression, Our results also shed light on a better structure-function relationship of HNF4 alpha and on p300 sequences involved in the interaction with HNF4 alpha.
引用
收藏
页码:1200 / 1210
页数:11
相关论文
共 48 条
[1]   E1A-ASSOCIATED P300 AND CREB-ASSOCIATED CBP BELONG TO A CONSERVED FAMILY OF COACTIVATORS [J].
ARANY, Z ;
SELLERS, WR ;
LIVINGSTON, DM ;
ECKNER, R .
CELL, 1994, 77 (06) :799-800
[2]   Role of CBP/P300 in nuclear receptor signalling [J].
Chakravarti, D ;
LaMorte, VJ ;
Nelson, MC ;
Nakajima, T ;
Schulman, IG ;
Juguilon, H ;
Montminy, M ;
Evans, RM .
NATURE, 1996, 383 (6595) :99-103
[3]   CREB-binding protein is a transcriptional coactivator for hepatocyte nuclear factor-4 and enhances apolipoprotein gene expression [J].
Dell, H ;
Hadzopoulou-Cladaras, M .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (13) :9013-9021
[4]  
DORIA A, 2000, CURR OPIN ENDOCRINOL, V7, P203
[5]  
Duncan SA, 1997, DEVELOPMENT, V124, P279
[6]   Regulation of a transcription factor network required for differentiation and metabolism [J].
Duncan, SA ;
Navas, MA ;
Dufort, D ;
Rossant, J ;
Stoffel, M .
SCIENCE, 1998, 281 (5377) :692-695
[7]   Critical structural elements and multitarget protein interactions of the transcriptional activator AF-1 of hepatocyte nuclear factor 4 [J].
Green, VJ ;
Kokkotou, E ;
Ladias, JAA .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (45) :29950-29957
[8]   FUNCTIONAL-CHARACTERIZATION OF THE L-TYPE PYRUVATE-KINASE GENE GLUCOSE RESPONSE COMPLEX [J].
GUERRA, MJMD ;
BERGOT, MO ;
MARTINEZ, A ;
CUIF, MH ;
KAHN, A ;
RAYMONDJEAN, M .
MOLECULAR AND CELLULAR BIOLOGY, 1993, 13 (12) :7725-7733
[9]  
HadzopoulouCladaras M, 1997, J BIOL CHEM, V272, P539
[10]   A missense mutation in hepatocyte nuclear factor-4α, resulting in a reduced transactivation activity, in human late-onset non-insulin-dependent diabetes mellitus [J].
Hani, E ;
Suaud, L ;
Boutin, P ;
Chèvre, JC ;
Durand, E ;
Philippi, A ;
Demenais, F ;
Vionnet, N ;
Furuta, H ;
Velho, G ;
Bell, GI ;
Laine, B ;
Froguel, P .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (03) :521-526